Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”.
trading_symbol | registrant_name | time | price | change | percentage_change |
---|---|---|---|---|---|
AVTR | Avantor, Inc. | 2025-10-16 17:55:19 | 14.7 | 0.13 | 0.89 |
trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AVTR | 0001722482 | Avantor, Inc. | US05352A1007 | — | 822758923 | NYSE | 3826 | Laboratory Analytical Instruments | 1231 | — | RADNOR CORPORATE CENTER, BUILDING ONE | RADNOR | PA | 19087 | UNITED STATES | US | (610) 386-1700 | RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA, 19087 | RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA, 19087 | Vail Holdco Corp | Pharmaceuticals | 1904 | Emmanuel Ligner | 14,500 | http://avantorsciences.com | 13,877,913,401 | 681,600,000 | 681,738,675 | Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”. | 2025-10-10 19:55:09 |
Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
---|---|---|---|---|---|---|
2024 | 14,407,779,658 | 529,866,257 | 3.8181 | 680,902,572 | 2,621,189 | 0.3864 |
2023 | 13,877,913,401 | -7,081,445,257 | -33.7866 | 678,281,383 | 3,837,877 | 0.569 |
2022 | 20,959,358,658 | 229,229,051 | 1.1058 | 674,443,506 | 64,475,410 | 10.5703 |
Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
---|---|---|---|---|---|---|---|---|
Randy Stone | Executive Vice President | 2023 | 415,385 | 0 | 2,105,342 | 34,192 | 33,200 | 4,588,116 |
Frederic Vanderhaegen | Executive Vice President | 2023 | 618,212 | 0 | 1,749,559 | 52,761 | 122,895 | 3,043,353 |
Michael Stubblefield | Chief Executive Officer, Director, President | 2023 | 1,140,000 | 0 | 8,529,219 | 188,100 | 36,500 | 12,338,767 |
R. Brent Jones | Chief Financial Officer, Executive Vice President | 2023 | 221,154 | 200,000 | 2,817,998 | 18,526 | 22,015 | 5,840,795 |
James Bramwell | Executive Vice President | 2023 | 497,981 | 0 | 1,749,559 | 39,384 | 33,650 | 2,840,235 |
Fiscal Year | Employee Count |
---|---|
2024 | 13,500 |
2023 | 14,500 |
2022 | 14,500 |
Fiscal Year | 2024 | 2023 | 2022 |
---|---|---|---|
Revenue | 6,783,600,000 | 6,967,200,000 | 7,512,400,000 |
Cost Of Revenue | 4,504,300,000 | 4,603,400,000 | 4,909,600,000 |
Gross Profit | 2,279,300,000 | 2,363,800,000 | 2,602,800,000 |
Research And Development Expenses | — | — | — |
General And Administrative Expenses | 1,641,100,000 | 1,506,600,000 | 1,472,600,000 |
Operating Expenses | — | — | — |
Operating Income | 1,084,800,000 | 696,400,000 | 1,130,200,000 |
Net Income | 711,500,000 | 321,100,000 | 686,500,000 |
Earnings Per Share Basic | 1.05 | 0.48 | 1.02 |
Earnings Per Share Diluted | 1.04 | 0.47 | 1.01 |
Weighted Average Shares Outstanding Basic | 679,600,000 | 675,600,000 | 650,900,000 |
Weighted Average Shares Outstanding Diluted | 681,900,000 | 678,400,000 | 679,400,000 |
Fiscal Year | 2024 | 2023 | 2022 |
---|---|---|---|
Cash And Cash Equivalents | 261,900,000 | 262,900,000 | 372,900,000 |
Marketable Securities Current | — | — | — |
Accounts Receivable | 1,034,500,000 | 1,150,200,000 | 1,218,400,000 |
Inventories | 731,500,000 | 828,100,000 | 913,500,000 |
Non Trade Receivables | — | — | — |
Other Assets Current | 118,700,000 | 143,700,000 | 153,100,000 |
Total Assets Current | 2,146,600,000 | 2,384,900,000 | 2,657,900,000 |
Marketable Securities Non Current | — | — | — |
Property Plant And Equipment | 708,100,000 | 737,500,000 | 727,000,000 |
Other Assets Non Current | 360,400,000 | 358,300,000 | 293,500,000 |
Total Assets Non Current | 9,967,900,000 | 10,587,800,000 | 10,806,400,000 |
Total Assets | 12,114,500,000 | 12,972,700,000 | 13,464,300,000 |
Accounts Payable | 662,800,000 | 625,900,000 | 758,200,000 |
Deferred Revenue | — | — | — |
Short Term Debt | 821,100,000 | 259,900,000 | 364,200,000 |
Other Liabilities Current | 306,800,000 | 411,200,000 | 364,100,000 |
Total Liabilities Current | 2,007,500,000 | 1,480,300,000 | 1,658,800,000 |
Long Term Debt | 4,055,800,000 | 5,536,600,000 | 6,287,500,000 |
Other Liabilities Non Current | 358,300,000 | 350,300,000 | 295,400,000 |
Total Liabilities Non Current | 4,150,300,000 | 6,239,800,000 | 6,950,100,000 |
Total Liabilities | 6,157,800,000 | 7,720,100,000 | 8,608,900,000 |
Common Stock | 3,937,700,000 | 3,830,100,000 | 3,785,300,000 |
Retained Earnings | 2,203,000,000 | 1,491,500,000 | 1,170,400,000 |
Accumulated Other Comprehensive Income | -184,000,000 | -69,000,000 | -100,300,000 |
Total Shareholders Equity | 5,956,700,000 | 5,252,600,000 | 4,855,400,000 |
Fiscal Year | 2024 | 2023 | 2022 |
---|---|---|---|
Depreciation And Amortization | 299,800,000 | 402,300,000 | 405,500,000 |
Share Based Compensation Expense | 46,800,000 | 40,500,000 | 45,800,000 |
Other Non Cash Income Expense | 300,000 | 700,000 | 7,000,000 |
Change In Accounts Receivable | -45,900,000 | -77,000,000 | 45,200,000 |
Change In Inventories | 18,500,000 | -30,300,000 | 112,500,000 |
Change In Non Trade Receivables | — | — | — |
Change In Other Assets | — | — | — |
Change In Accounts Payable | 59,600,000 | -139,600,000 | 15,600,000 |
Change In Other Liabilities | 37,700,000 | -48,600,000 | 179,300,000 |
Cash From Operating Activities | 840,800,000 | 870,000,000 | 843,600,000 |
Purchases Of Marketable Securities | — | — | — |
Sales Of Marketable Securities | — | — | — |
Acquisition Of Property Plant And Equipment | 148,800,000 | 146,400,000 | 133,400,000 |
Acquisition Of Business | 0 | 0 | 20,200,000 |
Other Investing Activities | -2,500,000 | -2,700,000 | -1,500,000 |
Cash From Investing Activities | 438,900,000 | -143,700,000 | -109,600,000 |
Tax Withholding For Share Based Compensation | — | — | — |
Payments Of Dividends | — | — | — |
Issuance Of Common Stock | — | 0 | 0 |
Repurchase Of Common Stock | — | — | — |
Issuance Of Long Term Debt | 0 | 0 | 327,200,000 |
Repayment Of Long Term Debt | 1,341,800,000 | 846,000,000 | 947,000,000 |
Other Financing Activities | -8,600,000 | -13,700,000 | -13,200,000 |
Cash From Financing Activities | -1,281,200,000 | -843,700,000 | -648,700,000 |
Change In Cash | -23,000,000 | -109,200,000 | 69,800,000 |
Cash At End Of Period | 261,900,000 | 262,900,000 | 372,900,000 |
Income Taxes Paid | 247,800,000 | 224,400,000 | 256,900,000 |
Interest Paid | 211,000,000 | 267,000,000 | 242,200,000 |
Fiscal Year | 2024 | 2023 | 2022 |
---|---|---|---|
Earnings Per Share | 1.05 | 0.48 | 1.02 |
Price To Earnings Ratio | 20.0667 | 47.5625 | 20.6765 |
Earnings Growth Rate | 118.75 | -52.9412 | 18.6047 |
Price Earnings To Growth Ratio | 0.169 | -0.8984 | 1.1114 |
Book Value Per Share | 8.765 | 7.7747 | 7.4595 |
Price To Book Ratio | 2.4039 | 2.9364 | 2.8273 |
Ebitda | 1,477,900,000 | 1,232,600,000 | 1,614,700,000 |
Enterprise Value | 18,934,172,000 | 20,957,548,000 | 20,006,281,000 |
Dividend Yield | — | — | — |
Dividend Payout Ratio | — | — | — |
Debt To Equity Ratio | 0.8187 | 1.1035 | 1.37 |
Capital Expenditures | 270,400,000 | 412,800,000 | 427,000,000 |
Free Cash Flow | 570,400,000 | 457,200,000 | 416,600,000 |
Return On Equity | 0.1194 | 0.0611 | 0.1414 |
One Year Beta | 0.8067 | 0.8376 | 0.9891 |
Three Year Beta | 0.929 | 0.9695 | 1.0906 |
Five Year Beta | 1.0491 | 1.0658 | 1.0867 |
Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
---|---|---|---|---|---|
LUCIER GREGORY T | Director | 2025-10-03 | 8,736 | A | 8,736 |
Gourdier Benoit | EVP, Bioscience Production | 2025-10-02 | 1,264 | D | 235,684 |
SUMME GREGORY L | Director | 2025-08-21 | 100,000 | A | 200,000 |
Ligner Emmanuel | Director, President and CEO | 2025-08-18 | 195,924 | A | 195,924 |
Ligner Emmanuel | Director, President and CEO | 2025-08-18 | 573,394 | A | 573,394 |
Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
---|---|---|---|---|---|---|
Gilbert Cisneros | 2025-09-12 | CA31 | Sale | 2025-08-13 | — | $1,001 - $15,000 |
Gilbert Cisneros | 2025-09-12 | CA31 | Sale (Partial) | 2025-08-12 | — | $1,001 - $15,000 |
Gilbert Cisneros | 2025-08-14 | CA31 | Sale (Partial) | 2025-07-23 | — | $1,001 - $15,000 |
Lisa McClain | 2025-08-13 | MI09 | Purchase | 2025-06-11 | Spouse | $1,001 - $15,000 |
Lisa McClain | 2025-08-13 | MI09 | Sale (Partial) | 2025-06-17 | Spouse | $1,001 - $15,000 |
Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
---|---|---|---|---|
Blue Trust, Inc. | 2025-09-30 | 314,758 | 25,221 | 12.48 |
CWM, LLC | 2025-09-30 | 37,000 | 2,935 | 12.6065 |
Pacer Advisors, Inc. | 2025-09-30 | 1,119,706 | 89,720 | 12.48 |
PRIVATE TRUST CO NA | 2025-09-30 | 23,637 | 1,894 | 12.4799 |
Vontobel Holding Ltd. | 2025-09-30 | 1,070,173 | 85,751 | 12.48 |
Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
---|---|---|---|---|---|---|
TRUST FOR PROFESSIONAL MANAGERS | 2025-08-31 | Column Small Cap Fund | CFSLX | 18,425 | 248,184.75 | 0.0518 |
Pacer Funds Trust | 2025-07-31 | Pacer Trendpilot US Mid Cap ETF | PTMC | 96,624 | 1,298,626.56 | 0.3099 |
Dimensional ETF Trust | 2025-07-31 | Dimensional U.S. Core Equity 2 ETF | DFAC | 12,658 | 170,123.52 | 0.0005 |
Dimensional ETF Trust | 2025-07-31 | Dimensional U.S. Targeted Value ETF | DFAT | 1,226,247 | 16,480,759.68 | 0.1528 |
FLEXSHARES TRUST | 2025-07-31 | FlexShares Morningstar US Market Factor Tilt Index Fund | TILT | 117,629 | 1,580,933.76 | 0.0916 |